Ada Schlossman

Title: Ada Schlossman: Innovator in Peptide Nucleic Acids

Introduction

Ada Schlossman is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of peptide nucleic acids, particularly through her innovative research and development efforts. Her work focuses on creating novel types of peptide nucleic acids with improved properties, which have important implications for therapeutic and diagnostic applications.

Latest Patents

Ada Schlossman holds a patent for "Positively-charged peptide nucleic acid analogs with improved properties." This invention relates to the development of positively charged PNA units that feature an ethylene linker between the backbone and the nucleobase. The patent encompasses oligonucleotide analogs and oligomers that utilize these units. Furthermore, her research highlights the potential of positively charged PNAs as novel delivery agents for antisense therapy, showcasing their therapeutic and diagnostic applications.

Career Highlights

Throughout her career, Ada has demonstrated a commitment to advancing the field of molecular biology. Her innovative approach to peptide nucleic acids has positioned her as a leading figure in this area of research. With a focus on improving the properties of these nucleic acids, she has contributed to the development of new methodologies that enhance their effectiveness in various applications.

Collaborations

Ada Schlossman has collaborated with notable researchers, including Yousuf Najajreh and Dan Gibson. These partnerships have allowed her to expand her research and explore new avenues in the field of peptide nucleic acids.

Conclusion

Ada Schlossman's work in the development of positively charged peptide nucleic acids represents a significant advancement in molecular biology. Her innovative contributions continue to influence therapeutic and diagnostic applications, making her a key figure in the field.